美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Scienture Holdings, Inc.

0.3602

-0.0052-1.42%

盤後：0.3550-0.0052-1.44%19:09 EDT

成交量：17.61萬

成交額：6.43萬

市值：1,463.52萬

市盈率：-0.20

高：0.3746

開：0.3575

低：0.3560

收：0.3654

52周最高：2.60

52周最低：0.2382

股本：4,063.08萬

流通股本：3,399.25萬

量比：0.49

換手率：0.52%

股息：- -

股息率：- -

每股收益(TTM):-1.8079

每股收益(LYR):-2.7049

淨資產收益率：-56.56%

總資產收益率：-10.82%

市淨率：0.22

市盈率(LYR):-0.13

資料載入中...

總覽公司新聞公告

Scienture 獲美國專利覆蓋 Rezenopy™（鹽酸納洛酮）鼻噴霧劑 10 毫克，知識產權保護期延至 2041 年

Scienture公布2026年第一季度財報：營收強勁增長，毛利率顯著擴張

Scienture Holdings與Summit Biosciences達成最終協議獲得Rezenopy美國獨家商業化權利

Scienture獲得1100萬美元非稀釋性債務融資加速已獲批產品組合擴張及研發管線推進

Scienture旗下Arbli™（氯沙坦鉀）口服混懸液獲第三項專利授權，市場獨佔期延長至2041年

Scienture Holdings獲納斯達克180天寬限期需在此期間恢復最低股價合規要求

Scienture發布年度股東信，展望新年重大進展與戰略重點

BUZZ-在達成擴大阿片類藥物過量噴劑使用範圍的協議後，賽恩圖公司股價上漲

Scienture Holdings, Inc.通過集團採購協議擴大Rezenopy™的商業可及性，覆蓋全美超5,000家機構

Scienture Holdings, Inc.盤中異動早盤股價大漲5.81%

Scienture Holdings, Inc.盤中異動早盤股價大跌7.02%報0.403美元

BUZZ-Scienture 在擴大高血壓藥物的使用範圍後大幅上漲

Scienture發布Arbli™商業進展：首款FDA即用型氯沙坦鉀口服混懸液上市更新

Scienture Holdings, Inc.盤中異動大幅拉升5.51%報0.507美元

BUZZ-Scienture Holdings 在美國 FDA 批准阿片類藥物過量噴霧劑後大漲

Scienture獲頒橙皮書可列專利覆蓋Rezenopy™——FDA批准用於搶救阿片類藥物過量的最高劑量鹽酸納洛酮鼻噴霧劑

Scienture Holdings, Inc.盤中異動股價大漲5.15%報0.556美元

Scienture 更新 Rezenopy® 的商業推出情況，這是一種 FDA 批准的最高強度納洛酮 Hcl 生命救助阿片類藥物過量應急治療

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SCNX/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SCNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCNX\",,,,,undefined,":{"symbol":"SCNX","market":"US","secType":"STK","nameCN":"Scienture Holdings, Inc.","latestPrice":0.3602,"timestamp":1782504000000,"preClose":0.3654,"halted":0,"volume":176127,"hourTrading":{"tag":"盘后","latestPrice":0.355,"preClose":0.3602,"latestTime":"19:09 EDT","volume":6374,"amount":2264.2552,"timestamp":1782515365988,"change":-0.0052,"changeRate":-0.014436,"amplitude":0.013881},"delay":0,"changeRate":-0.01423097974822108,"floatShares":33992500,"shares":40630815,"eps":-1.807909,"marketStatus":"已收盤","change":-0.0052,"latestTime":"06-26 16:00:00 EDT","open":0.3575,"high":0.374599,"low":0.356,"amount":64253.77678881,"amplitude":0.0509,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.807909,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1782720000000},"marketStatusCode":5,"adr":0,"listingDate":1581570000000,"exchange":"NASDAQ","adjPreClose":0.3654,"preHourTrading":{"tag":"盘前","latestPrice":0.3705,"preClose":0.3654,"latestTime":"09:19 EDT","volume":2012,"amount":717.0421131200001,"timestamp":1782479974156,"change":0.0051,"changeRate":0.013957,"amplitude":0.079091},"postHourTrading":{"tag":"盘后","latestPrice":0.355,"preClose":0.3602,"latestTime":"19:09 EDT","volume":6374,"amount":2264.2552,"timestamp":1782515365988,"change":-0.0052,"changeRate":-0.014436,"amplitude":0.013881},"volumeRatio":0.48697},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SCNX\",,,,,undefined,":{"symbol":"SCNX","floatShares":33992500,"roa":"-10.82%","roe":"-56.56%","lyrEps":-2.704855,"volumeRatio":0.48697,"shares":40630815,"dividePrice":0,"high":0.374599,"amplitude":0.0509,"preClose":0.3654,"low":0.356,"week52Low":0.2382,"pbRate":"0.22","psRate":"30.64","week52High":2.6,"institutionHeld":0,"latestPrice":0.3602,"eps":-1.807909,"divideRate":0,"volume":176127,"delay":0,"ttmEps":-1.807909,"open":0.3575,"prevYearClose":0.51,"prevWeekClose":0.3818,"prevMonthClose":0.413,"prevQuarterClose":0.285,"fiveDayClose":0.3818,"twentyDayClose":0.4189,"sixtyDayClose":0.285},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SCNX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-15","symbol":"SCNX","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.08},{"market":"US","date":"2026-03-30","symbol":"SCNX","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-1.76},{"market":"US","date":"2025-11-12","symbol":"SCNX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"post","actualEps":-0.19},{"market":"US","date":"2025-08-12","symbol":"SCNX","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.48},{"market":"US","date":"2025-05-12","symbol":"SCNX","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.33}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SCNX\",market:\"US\",,,undefined,":[{"executeDate":"2024-03-25","recordDate":"2024-03-18","paymentDate":"2024-03-22","value":8,"currency":"USD"},{"executeDate":"2024-07-19","recordDate":"2024-07-19","paymentDate":"2024-07-24","value":1.5,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SCNX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1771992000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SCNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SCNX","date":"2026-06-25","current":-0.199236,"percent":0.679634,"low":-4.335221,"twenty":-1.056231,"median":-0.769806,"eighty":1.245124,"high":3.580326,"avg":-0.214985,"sd":1.570683,"marketCap":14964329},"quantilePoints":[{"date":"2024-09-27","current":-0.598388,"twenty":-0.613397,"median":-0.60738,"eighty":-0.601331,"marketCap":10677383},{"date":"2024-10-04","current":-0.575439,"twenty":-0.613397,"median":-0.603293,"eighty":-0.596854,"marketCap":10267882},{"date":"2024-10-11","current":-0.569717,"twenty":-0.610449,"median":-0.596691,"eighty":-0.575112,"marketCap":10165786},{"date":"2024-10-18","current":-3.316594,"twenty":-3.320439,"median":-0.603293,"eighty":-0.579563,"marketCap":59179885},{"date":"2024-10-25","current":-3.532893,"twenty":-3.381003,"median":-0.61388,"eighty":-0.587997,"marketCap":63039443},{"date":"2024-10-31","current":-3.835472,"twenty":-3.470407,"median":-1.920019,"eighty":-0.593421,"marketCap":68438535},{"date":"2024-11-08","current":-3.92083,"twenty":-3.680939,"median":-3.316594,"eighty":-0.596527,"marketCap":69961625},{"date":"2024-11-15","current":3.401097,"twenty":-3.547313,"median":-1.920019,"eighty":-0.574948,"marketCap":68584767},{"date":"2024-11-22","current":3.456572,"twenty":-3.511744,"median":-0.611468,"eighty":3.395976,"marketCap":69703464},{"date":"2024-11-29","current":3.136519,"twenty":-3.477174,"median":-0.603293,"eighty":3.362691,"marketCap":63249440},{"date":"2024-12-06","current":3.110915,"twenty":-3.463831,"median":-0.596691,"eighty":3.285878,"marketCap":62733118},{"date":"2024-12-13","current":3.337086,"twenty":-3.450219,"median":-0.582313,"eighty":3.360949,"marketCap":67293962},{"date":"2024-12-20","current":3.469375,"twenty":-3.422821,"median":-0.572987,"eighty":3.384019,"marketCap":69961625},{"date":"2024-12-27","current":2.837803,"twenty":-3.405517,"median":1.134043,"eighty":3.366915,"marketCap":57225683},{"date":"2025-01-03","current":2.561875,"twenty":-3.372831,"median":2.613767,"eighty":3.343052,"marketCap":51661454},{"date":"2025-01-10","current":2.200068,"twenty":-3.341588,"median":2.571818,"eighty":3.331965,"marketCap":44365450},{"date":"2025-01-17","current":1.983099,"twenty":-3.320439,"median":2.304552,"eighty":3.323431,"marketCap":39990159},{"date":"2025-01-24","current":1.820372,"twenty":-3.285831,"median":2.061208,"eighty":3.308922,"marketCap":36708691},{"date":"2025-01-31","current":1.69236,"twenty":-3.231997,"median":1.995032,"eighty":3.279477,"marketCap":34127269},{"date":"2025-02-07","current":1.431997,"twenty":-2.180107,"median":1.896311,"eighty":3.250031,"marketCap":28876920},{"date":"2025-02-14","current":1.375585,"twenty":-0.618263,"median":1.823627,"eighty":3.227841,"marketCap":27739344},{"date":"2025-02-21","current":1.184652,"twenty":-0.615326,"median":1.76613,"eighty":3.213059,"marketCap":23889088},{"date":"2025-02-28","current":1.145598,"twenty":-0.611128,"median":1.69236,"eighty":3.194897,"marketCap":23101536},{"date":"2025-03-07","current":1.045792,"twenty":-0.608474,"median":1.646775,"eighty":3.193463,"marketCap":21088902},{"date":"2025-03-14","current":0.538084,"twenty":-0.602312,"median":1.540482,"eighty":3.184314,"marketCap":10850721},{"date":"2025-03-21","current":0.733356,"twenty":-0.598212,"median":1.425488,"eighty":3.168951,"marketCap":14788483},{"date":"2025-03-28","current":0.715999,"twenty":-0.597181,"median":1.375585,"eighty":3.16127,"marketCap":14438460},{"date":"2025-04-04","current":1.435684,"twenty":-0.595056,"median":1.425488,"eighty":3.153589,"marketCap":13015619},{"date":"2025-04-11","current":1.12784,"twenty":-0.589891,"median":1.375585,"eighty":3.136519,"marketCap":10224770},{"date":"2025-04-17","current":1.246836,"twenty":-0.582313,"median":1.328698,"eighty":3.136519,"marketCap":11303565},{"date":"2025-04-25","current":1.311304,"twenty":-0.575439,"median":1.30873,"eighty":3.110915,"marketCap":11888016},{"date":"2025-05-02","current":1.325247,"twenty":-0.574621,"median":1.311304,"eighty":3.085311,"marketCap":12014418},{"date":"2025-05-09","current":1.290735,"twenty":-0.571352,"median":1.304933,"eighty":2.846338,"marketCap":11701542},{"date":"2025-05-16","current":-0.774291,"twenty":-0.575439,"median":1.297499,"eighty":2.837803,"marketCap":11803474},{"date":"2025-05-23","current":-0.765773,"twenty":-0.597508,"median":1.28756,"eighty":2.645772,"marketCap":11673621},{"date":"2025-05-30","current":-0.779626,"twenty":-0.610109,"median":1.27693,"eighty":2.645772,"marketCap":11884796},{"date":"2025-06-06","current":-0.894836,"twenty":-0.730719,"median":1.246836,"eighty":2.594563,"marketCap":13641086},{"date":"2025-06-13","current":-0.959367,"twenty":-0.765773,"median":1.225767,"eighty":2.581761,"marketCap":14624818},{"date":"2025-06-20","current":-0.856031,"twenty":-0.771761,"median":1.212713,"eighty":2.569829,"marketCap":13049535},{"date":"2025-06-27","current":-0.841318,"twenty":-0.780624,"median":1.184652,"eighty":2.512356,"marketCap":12825244},{"date":"2025-07-03","current":-1.247608,"twenty":-0.792738,"median":1.179469,"eighty":2.409427,"marketCap":19018822},{"date":"2025-07-11","current":-1.411087,"twenty":-0.813268,"median":1.154073,"eighty":2.262758,"marketCap":21510943},{"date":"2025-07-18","current":-1.789672,"twenty":-0.855997,"median":1.145598,"eighty":2.175929,"marketCap":27282172},{"date":"2025-07-25","current":-1.746651,"twenty":-0.908602,"median":1.122616,"eighty":2.108316,"marketCap":26626350},{"date":"2025-08-01","current":-1.669213,"twenty":-0.977436,"median":1.076168,"eighty":2.04385,"marketCap":25445872},{"date":"2025-08-08","current":-2.380911,"twenty":-1.247608,"median":1.000228,"eighty":2.013475,"marketCap":36295155},{"date":"2025-08-15","current":-0.96959,"twenty":-1.381833,"median":0.872216,"eighty":1.999328,"marketCap":19518727},{"date":"2025-08-22","current":-0.980842,"twenty":-1.373229,"median":0.796277,"eighty":1.985962,"marketCap":19745239},{"date":"2025-08-29","current":-0.980746,"twenty":-1.319883,"median":0.733356,"eighty":1.970949,"marketCap":19743303},{"date":"2025-09-05","current":-0.893537,"twenty":-1.247608,"median":0.689962,"eighty":1.941441,"marketCap":17987698},{"date":"2025-09-12","current":-0.924958,"twenty":-1.220075,"median":0.629211,"eighty":1.895443,"marketCap":18620241},{"date":"2025-09-19","current":-0.916402,"twenty":-1.093717,"median":0.546763,"eighty":1.883542,"marketCap":18448004},{"date":"2025-09-26","current":-0.858058,"twenty":-1.027837,"median":-0.570534,"eighty":1.845235,"marketCap":17273474},{"date":"2025-10-03","current":-0.892899,"twenty":-1.021738,"median":-0.575439,"eighty":1.825579,"marketCap":17974872},{"date":"2025-10-10","current":-0.787446,"twenty":-1.012393,"median":-0.59383,"eighty":1.815599,"marketCap":15852002},{"date":"2025-10-17","current":-0.608083,"twenty":-1.007669,"median":-0.598388,"eighty":1.784356,"marketCap":12241257},{"date":"2025-10-24","current":-2.680141,"twenty":-1.007669,"median":-0.596691,"eighty":1.730959,"marketCap":53953668},{"date":"2025-10-31","current":-0.791363,"twenty":-1.019031,"median":-0.603293,"eighty":1.707894,"marketCap":15930858},{"date":"2025-11-07","current":-1.280832,"twenty":-1.093717,"median":-0.610618,"eighty":1.69236,"marketCap":25784310},{"date":"2025-11-14","current":-1.151144,"twenty":-1.207623,"median":-0.619577,"eighty":1.689756,"marketCap":23173577},{"date":"2025-11-21","current":-1.10301,"twenty":-1.174718,"median":-0.731804,"eighty":1.679333,"marketCap":22671994},{"date":"2025-11-28","current":-1.184253,"twenty":-1.184253,"median":-0.746883,"eighty":1.679299,"marketCap":24341921},{"date":"2025-12-05","current":-1.19809,"twenty":-1.186625,"median":-0.754071,"eighty":1.614251,"marketCap":24626336},{"date":"2025-12-12","current":-1.198288,"twenty":-1.205799,"median":-0.765773,"eighty":1.560053,"marketCap":24630400},{"date":"2025-12-19","current":-0.985197,"twenty":-1.202636,"median":-0.770075,"eighty":1.540482,"marketCap":20250398},{"date":"2025-12-26","current":-1.058534,"twenty":-1.199158,"median":-0.774377,"eighty":1.505767,"marketCap":21757801},{"date":"2026-01-02","current":-1.008127,"twenty":-1.198169,"median":-0.779626,"eighty":1.460246,"marketCap":20721715},{"date":"2026-01-09","current":-1.092533,"twenty":-1.19726,"median":-0.785773,"eighty":1.433472,"marketCap":22456651},{"date":"2026-01-16","current":-1.033232,"twenty":-1.190657,"median":-0.792532,"eighty":1.424186,"marketCap":21237727},{"date":"2026-01-23","current":-1.008127,"twenty":-1.185676,"median":-0.799919,"eighty":1.415507,"marketCap":20721715},{"date":"2026-01-30","current":-0.962267,"twenty":-1.184253,"median":-0.804018,"eighty":1.403888,"marketCap":19779080},{"date":"2026-02-06","current":-0.84999,"twenty":-1.182312,"median":-0.81198,"eighty":1.386796,"marketCap":17471250},{"date":"2026-02-13","current":-0.850978,"twenty":-1.176993,"median":-0.828904,"eighty":1.372015,"marketCap":17491565},{"date":"2026-02-20","current":-0.812432,"twenty":-1.169902,"median":-0.82127,"eighty":1.36651,"marketCap":16699264},{"date":"2026-02-27","current":-0.880826,"twenty":-1.155018,"median":-0.816538,"eighty":1.358466,"marketCap":18105091},{"date":"2026-03-06","current":-0.794641,"twenty":-1.149758,"median":-0.814485,"eighty":1.328008,"marketCap":16333587},{"date":"2026-03-13","current":-1.009116,"twenty":-1.140915,"median":-0.812432,"eighty":1.323164,"marketCap":20742031},{"date":"2026-03-20","current":-0.903756,"twenty":-1.124163,"median":-0.826728,"eighty":1.314432,"marketCap":18576408},{"date":"2026-03-27","current":-0.894466,"twenty":-1.109385,"median":-0.840106,"eighty":1.312518,"marketCap":18385443},{"date":"2026-04-02","current":-0.286779,"twenty":-1.107161,"median":-0.827455,"eighty":1.311304,"marketCap":11904828},{"date":"2026-04-10","current":-0.333759,"twenty":-1.10301,"median":-0.820415,"eighty":1.306155,"marketCap":13855107},{"date":"2026-04-17","current":-0.381719,"twenty":-1.093522,"median":-0.81198,"eighty":1.303711,"marketCap":15846017},{"date":"2026-04-24","current":-0.409124,"twenty":-1.092533,"median":-0.804018,"eighty":1.297499,"marketCap":16983680},{"date":"2026-05-01","current":-0.382698,"twenty":-1.092138,"median":-0.799919,"eighty":1.297499,"marketCap":15886648},{"date":"2026-05-08","current":-0.415878,"twenty":-1.087196,"median":-0.793759,"eighty":1.293496,"marketCap":17264033},{"date":"2026-05-15","current":-0.402273,"twenty":-1.087196,"median":-0.791676,"eighty":1.290735,"marketCap":16699264},{"date":"2026-05-22","current":-0.388342,"twenty":-1.079109,"median":-0.790688,"eighty":1.284385,"marketCap":16252326},{"date":"2026-05-29","current":-0.406691,"twenty":-1.069923,"median":-0.785773,"eighty":1.283943,"marketCap":17020248},{"date":"2026-06-05","current":-0.368925,"twenty":-1.06652,"median":-0.782121,"eighty":1.272789,"marketCap":15439709},{"date":"2026-06-12","current":-0.364556,"twenty":-1.060076,"median":-0.776602,"eighty":1.258984,"marketCap":15256871},{"date":"2026-06-18","current":-0.376498,"twenty":-1.058534,"median":-0.774334,"eighty":1.250591,"marketCap":15756630},{"date":"2026-06-25","current":-0.357566,"twenty":-1.056231,"median":-0.769806,"eighty":1.245124,"marketCap":14964329}],"updateTime":1782530288121},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SCNX\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1164800395","title":"Scienture 獲美國專利覆蓋 Rezenopy™（鹽酸納洛酮）鼻噴霧劑 10 毫克，知識產權保護期延至 2041 年","url":"https://stock-news.laohu8.com/highlight/detail?id=1164800395","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164800395?lang=zh_tw&edition=fundamental","pubTime":"2026-06-02 20:06","pubTimestamp":1780401986,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc. 成功获得一项美国专利，该专利覆盖了其产品 Rezenopy™（盐酸纳洛酮）鼻喷雾剂 10 毫克的特定范围。此项专利的授予，显著强化了公司对该关键产品的知识产权保护，其保护期限将一直持续到 2041 年。\n这项专利不仅巩固了 Scienture 在其核心治疗领域的技术壁垒，也为 Rezenopy™ 这一重要药品的商业前景提供了长期、稳固的法律保障。通过将专利保护期延长至 2041 年，公司有效维护了其市场独占地位，为未来的持续发展和市场拓展奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197083931","title":"Scienture公布2026年第一季度財報：營收強勁增長，毛利率顯著擴張","url":"https://stock-news.laohu8.com/highlight/detail?id=1197083931","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197083931?lang=zh_tw&edition=fundamental","pubTime":"2026-05-18 20:39","pubTimestamp":1779107951,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.发布了2026年第一季度财务业绩及业务进展。报告期内，公司实现了显著的营收增长，同时毛利率亦获得有力扩张，展现出强劲的业务发展势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143008554","title":"Scienture Holdings與Summit Biosciences達成最終協議 獲得Rezenopy美國獨家商業化權利","url":"https://stock-news.laohu8.com/highlight/detail?id=1143008554","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143008554?lang=zh_tw&edition=fundamental","pubTime":"2026-05-07 20:14","pubTimestamp":1778156056,"startTime":"0","endTime":"0","summary":"Scienture Holdings已与Summit Biosciences签署最终协议，获得抗抑郁药物Rezenopy在美国市场的独家商业化权利。此次合作将进一步加强Scienture Holdings在神经科学领域的市场布局。\n根据协议条款，Scienture Holdings将负责Rezenopy在美国境内的所有商业化活动，包括市场推广、销售和分销。该交易标志着公司向精神健康治疗领域迈出重要一步。\nRezenopy作为一种新型抗抑郁药物，在临床试验中展现出良好的疗效和安全性。此次独家授权协议的达成，将为Scienture Holdings带来新的收入增长点，并扩大其产品管线。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178090977","title":"Scienture獲得1100萬美元非稀釋性債務融資 加速已獲批產品組合擴張及研發管線推進","url":"https://stock-news.laohu8.com/highlight/detail?id=1178090977","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1178090977?lang=zh_tw&edition=fundamental","pubTime":"2026-05-07 20:06","pubTimestamp":1778155590,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc. (简称Scienture) 近日成功获得1100万美元非稀释性债务融资。此次融资将主要用于加速公司已获批产品组合的商业化增长，并推动研发管线的持续进展。非稀释性融资模式使得Scienture能够在不动用股权的情况下获得资金支持，有效保护了现有股东利益。这笔资金将助力公司扩大市场份额，加强产品创新，为长期发展注入新动能。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196037398","title":"Scienture旗下Arbli™（氯沙坦鉀）口服混懸液獲第三項專利授權，市場獨佔期延長至2041年","url":"https://stock-news.laohu8.com/highlight/detail?id=1196037398","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196037398?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 20:06","pubTimestamp":1778069213,"startTime":"0","endTime":"0","summary":"生物制药企业Scienture Holdings, Inc.（SCNX）宣布，其核心产品Arbli™（氯沙坦钾）口服混悬液再度获得一项关键专利授权。这标志着该药物在知识产权保护方面取得里程碑式进展，已累计拥有三项核心专利护城河。\n最新专利授权将有效构筑技术壁垒，确保Arbli™在高血压治疗领域的市场独占地位延续至2041年。通过强化知识产权布局，Scienture不仅巩固了产品商业价值，更为长期营收增长注入确定性。此次专利拓展进一步凸显公司对创新研发的持续投入与战略前瞻性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164857739","title":"Scienture Holdings獲納斯達克180天寬限期 需在此期間恢復最低股價合規要求","url":"https://stock-news.laohu8.com/highlight/detail?id=1164857739","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164857739?lang=zh_tw&edition=fundamental","pubTime":"2026-04-15 20:05","pubTimestamp":1776254717,"startTime":"0","endTime":"0","summary":"纳斯达克交易所已正式授予Scienture Holdings, Inc.额外180天的宽限期，该公司须在此期间内将其股价提升至1美元以上，以满足交易所的最低报价规定。\n此次延期为这家生物科技企业提供了关键缓冲期，使其能够通过战略调整或业务优化等方式重新达到上市标准。若未能按时合规，公司将面临退市风险。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160265228","title":"Scienture發布年度股東信，展望新年重大進展與戰略重點","url":"https://stock-news.laohu8.com/highlight/detail?id=1160265228","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160265228?lang=zh_tw&edition=fundamental","pubTime":"2026-04-06 20:06","pubTimestamp":1775477173,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.（简称Scienture）近日向股东发布了年度更新报告，详细阐述了公司在过去一年取得的重大进展，并明确了新一年的战略发展方向。\n报告显示，公司在多个关键业务领域实现了突破性成长，包括技术研发、市场拓展及运营效率提升。管理层强调，这些成果为未来的持续增长奠定了坚实基础。\n展望未来，Scienture将聚焦于加速创新、深化客户合作以及优化资本结构三大战略重点。公司表示，将通过持续投入研发和战略性资源分配，进一步提升长期股东价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618475199","title":"BUZZ-在達成擴大阿片類藥物過量噴劑使用範圍的協議後，賽恩圖公司股價上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2618475199","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618475199?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 20:41","pubTimestamp":1773232916,"startTime":"0","endTime":"0","summary":"** 2025 年 3 月从 Summit Biosciences 获得该产品在美国的独家代理权 - SCNX** SCNX 在 2025 年上涨了约 28%(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260311:nL4T3ZZ18T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU0211331839.USD","IE0002270589.USD","BK4167","CVS","LU0072461881.USD","IE00BSNM7G36.USD","BK4504","IE00B19Z3581.USD","BK4585","LU0320765489.SGD","LU0162691827.USD","IE00B19Z3B42.SGD","LU0061475181.USD","LU0208291251.USD","IE00BZ1G4Q59.USD","LU0432979614.USD","IE00BKVL7J92.USD","BK4581","LU0006061336.USD","BK4550","BK4196","LU0070302665.USD","LU1699723380.USD","LU1059921491.USD","LU1571399168.USD","IE00B7SZLL34.SGD","BK4588","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176660109","title":"Scienture Holdings, Inc.通過集團採購協議擴大Rezenopy™的商業可及性，覆蓋全美超5,000家機構","url":"https://stock-news.laohu8.com/highlight/detail?id=1176660109","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176660109?lang=zh_tw&edition=fundamental","pubTime":"2026-03-11 20:13","pubTimestamp":1773231202,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc. (SCNX) 已成功拓展其旗舰产品Rezenopy™的商业覆盖范围。该产品是当前获得美国食品药品监督管理局（FDA）批准的最高剂量纳洛酮鼻喷雾剂。通过达成一系列集团采购组织（GPO）协议，公司显著提升了这款关键药物的市场可及性。\n此次合作将直接惠及美国境内超过5,000家医疗机构，包括医院、诊所和社区健康中心等。此举旨在确保更多有需要的人群能够及时获得这种高效的阿片类药物过量逆转疗法。Rezenopy™的高剂量特性为其在紧急情况下快速起效提供了保障，对应对阿片危机具有重要价值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614009750","title":"Scienture Holdings, Inc.盤中異動 早盤股價大漲5.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614009750","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614009750?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 22:43","pubTimestamp":1772116987,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日22时43分，Scienture Holdings, Inc.股票出现异动，股价快速拉升5.81%。截至发稿，该股报0.450美元/股，成交量5.4598万股，换手率0.13%，振幅4.47%。Scienture Holdings, Inc.股票所在的医药零售行业中，整体涨幅为0.00%。其相关个股中，Scienture Holdings, Inc.、Wellgistics Health, Inc.、Ridgetech, Inc.涨幅较大，Scienture Holdings, Inc.、Wellgistics Health, Inc.、石榴云医较为活跃，换手率分别为0.13%、0.03%、0.03%，振幅较大的相关个股有Scienture Holdings, Inc.、Wellgistics Health, Inc.、High Tide Inc.，振幅分别为4.47%、1.98%、1.17%。Scienture Holdings, Inc.公司简介：Scienture Holdings Inc 是一家综合性医疗服务和医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226224308a4cbfdd4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226224308a4cbfdd4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612490010","title":"Scienture Holdings, Inc.盤中異動 早盤股價大跌7.02%報0.403美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612490010","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612490010?lang=zh_tw&edition=fundamental","pubTime":"2026-02-17 22:32","pubTimestamp":1771338769,"startTime":"0","endTime":"0","summary":"北京时间2026年02月17日22时32分，Scienture Holdings, Inc.股票出现波动，股价大幅下跌7.02%。截至发稿，该股报0.403美元/股，成交量29.4963万股，换手率0.73%，振幅0.72%。Scienture Holdings, Inc.股票所在的医药零售行业中，整体涨幅为0.00%。其相关个股中，Petmed Express, Inc.、Ridgetech, Inc.、High Tide Inc.涨幅较大，Scienture Holdings, Inc.、High Tide Inc.、Petmed Express, Inc.较为活跃，换手率分别为0.82%、0.05%、0.02%，振幅较大的相关个股有Scienture Holdings, Inc.、Wellgistics Health, Inc.、High Tide Inc.，振幅分别为3.58%、1.87%、1.30%。Scienture Holdings, Inc.公司简介：Scienture Holdings Inc 是一家综合性医疗服务和医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217223250a4ad86ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217223250a4ad86ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608879064","title":"BUZZ-Scienture 在擴大高血壓藥物的使用範圍後大幅上漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879064","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608879064?lang=zh_tw&edition=fundamental","pubTime":"2026-02-03 21:17","pubTimestamp":1770124643,"startTime":"0","endTime":"0","summary":"BUZZ-Scienture 在扩大高血压药物的使用范围后大幅上涨2月3日 - ** 制药商 Scienture Holdings SCNX.O 股价盘前上涨 10.34% 至 0.4993 美元** 该公司称已扩大了Arbli的供应范围，Arbli是其治疗高血压的即用型液体洛沙坦。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nL4S3YZ1AJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119635143","title":"Scienture發布Arbli™商業進展：首款FDA即用型氯沙坦鉀口服混懸液上市更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1119635143","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119635143?lang=zh_tw&edition=fundamental","pubTime":"2026-02-03 21:05","pubTimestamp":1770123928,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.（简称Scienture）近日就其创新药物Arbli™的商业化进展发布最新动态。该产品作为全球首款获得美国食品药品监督管理局（FDA）批准的即用型氯沙坦钾口服混悬液，标志着高血压治疗领域的重要突破。\nArbli™的上市为无法吞咽标准片剂的患者提供了便捷解决方案，其即开即用的特性显著提升了用药依从性。公司正通过多渠道营销策略加速市场渗透，并与关键分销伙伴建立合作网络以扩大药品可及性。\n此次商业更新凸显了Scienture在心血管疾病治疗领域的研发实力。随着Arbli™逐步覆盖更多医疗机构的患者群体，公司有望进一步巩固其在专科药物市场的竞争优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606769374","title":"Scienture Holdings, Inc.盤中異動 大幅拉升5.51%報0.507美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606769374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606769374?lang=zh_tw&edition=fundamental","pubTime":"2026-01-28 02:20","pubTimestamp":1769538021,"startTime":"0","endTime":"0","summary":"北京时间2026年01月28日02时20分，Scienture Holdings, Inc.股票出现异动，股价大幅拉升5.51%。Scienture Holdings, Inc.股票所在的医药零售行业中，整体涨幅为0.60%。其相关个股中，Scienture Holdings, Inc.、Wellgistics Health, Inc.、生研生物涨幅较大，Scienture Holdings, Inc.、Petmed Express, Inc.、Wellgistics Health, Inc.较为活跃，换手率分别为0.95%、0.47%、0.24%，振幅较大的相关个股有石榴云医、生研生物、Scienture Holdings, Inc.，振幅分别为7.11%、6.15%、5.66%。Scienture Holdings, Inc.公司简介：Scienture Holdings Inc 是一家综合性医疗服务和医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128022022a45d0ced&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128022022a45d0ced&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603567619","title":"BUZZ-Scienture Holdings 在美國 FDA 批准阿片類藥物過量噴霧劑後大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2603567619","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603567619?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 21:26","pubTimestamp":1768397174,"startTime":"0","endTime":"0","summary":"BUZZ-Scienture Holdings 在美国 FDA 批准阿片类药物过量喷雾剂后大涨1月14日 - ** 专业制药公司 Scienture Holdings SCNX.O 股价盘前上涨 19.99% 至 0.6472 美元** 该公司称  美国 FDA 批准了一种新型高剂量鼻腔喷雾剂 Rezenopy，用于治疗阿片类药物过量。** 该喷雾剂可提供 10 毫克纳洛酮，用于逆转包括芬太尼在内的强效阿片类药物的过量用药。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nL4T3YF19S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130102774.USD","LU1201861249.SGD","LU0477156953.USD","BK4121","LU0130517989.USD","LU0477156797.USD","LU0882574055.USD","LU0528227936.USD","LU0980610538.SGD","LU1791710582.SGD","BK4585","LU0130103400.USD","LU1989764748.USD","BK4588","SCNX","LU0130518102.USD","BK4530","LU1201861165.SGD","BK4167","LU0648000940.SGD","LU1791710400.SGD","LU0648001328.SGD","LU1261432733.SGD","LU0198837287.USD","LU1989764664.SGD","IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169867640","title":"Scienture獲頒橙皮書可列專利 覆蓋Rezenopy™——FDA批准用於搶救阿片類藥物過量的最高劑量鹽酸納洛酮鼻噴霧劑","url":"https://stock-news.laohu8.com/highlight/detail?id=1169867640","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169867640?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 21:11","pubTimestamp":1768396264,"startTime":"0","endTime":"0","summary":"Scienture Holdings, Inc.宣布获得一项可列入橙皮书的专利授权，该专利覆盖其旗下产品Rezenopy™。这款鼻喷雾剂是经美国食品药品监督管理局批准、用于抢救阿片类药物过量急症的最高剂量盐酸纳洛酮制剂。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602319135","title":"Scienture Holdings, Inc.盤中異動 股價大漲5.15%報0.556美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2602319135","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602319135?lang=zh_tw&edition=fundamental","pubTime":"2026-01-08 23:30","pubTimestamp":1767886217,"startTime":"0","endTime":"0","summary":"北京时间2026年01月08日23时30分，Scienture Holdings, Inc.股票出现异动，股价快速拉升5.15%。Scienture Holdings, Inc.股票所在的医药零售行业中，整体跌幅为0.12%。其相关个股中，Scienture Holdings, Inc.、Wellgistics Health, Inc.、High Tide Inc.涨幅较大，Petmed Express, Inc.、Scienture Holdings, Inc.、生研生物较为活跃，换手率分别为0.40%、0.36%、0.17%，振幅较大的相关个股有石榴云医、Scienture Holdings, Inc.、生研生物，振幅分别为9.15%、6.05%、3.66%。Scienture Holdings, Inc.公司简介：Scienture Holdings Inc 是一家综合性医疗服务和医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108233017953c3be3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108233017953c3be3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4167","SCNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1156910514","title":"Scienture 更新 Rezenopy® 的商業推出情況，這是一種 FDA 批准的最高強度納洛酮 Hcl 生命救助阿片類藥物過量應急治療","url":"https://stock-news.laohu8.com/highlight/detail?id=1156910514","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1156910514?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 21:07","pubTimestamp":1766408857,"startTime":"0","endTime":"0","summary":"Scienture 更新 Rezenopy® 的商业推出情况，这是一种 FDA 批准的最高强度纳洛酮 Hcl 生命救助阿片类药物过量应急治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SCNX","BK4167"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":18,"code":"91000000","status":"200"}]}}